mPGES1-IN-16

CAS No. 1915003-93-8

mPGES1-IN-16( —— )

Catalog No. M13001 CAS No. 1915003-93-8

mPGES1-IN-16 is a potent and selective mPGES-1 inhibitor with IC50 of 1 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    mPGES1-IN-16
  • Note
    Research use only, not for human use.
  • Brief Description
    mPGES1-IN-16 is a potent and selective mPGES-1 inhibitor with IC50 of 1 nM.
  • Description
    mPGES1-IN-16 is a potent and selective mPGES-1 inhibitor with IC50 of 1 nM; displays no activity against a panel of 35 receptors, ion channels, and hERG; shows IC50/IC80 of 6 nM/24 nM for inhibition of PGE2 formation in vitro in LPS-stimulated human whole blood (HWB); orally bioavailable in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    PGE synthase
  • Recptor
    PGE synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1915003-93-8
  • Formula Weight
    485.628
  • Molecular Formula
    C30H35N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    2-(2-((1S,2S)-2-(1-(8-methylquinolin-2-yl)piperidine-4-carboxamido)cyclopentyl)ethyl)benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Partridge KM, et al. Bioorg Med Chem Lett. 2017 Mar 15;27(6):1478-1483.
molnova catalog
related products
  • MF63

    MF63 is a potent, selective, and orally active mPGES-1 inhibitor with IC50 of 1.3 nM for human mPGES-1 enzyme.

  • ALPHA-PINENE

    α-Pinene is a bicyclic monoterpene found in pine trees and other plants, including Cannabis with diverse biological activities.

  • Crisdesalazine

    Crisdesalazine (AAD-2004, AAD2004) is a derivative of aspirin that inhibits microsomal PGE(2) synthase-1 (mPGES-1) activity in response to both LPS-treated BV2 cell with IC50 of 230 nM and recombinant human mPGES-1 protein with IC50 of 249 nM in vitro.